Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Obesity and response to food marketing

Published on: 13/03/2021 Reading time: 1 min
Un repas de fast food
Retour à la recherche

Researchers from the Paris Brain Institute, INSEAD, the Nutrition Department of the Pitié-Salpêtrière Hospital (AP-HP/Sorbonne Université), EPHE and the University of British Columbia, provide new evidence for a reciprocal relationship between obesity and susceptibility to food marketing and that this relationship is not a stable individual predisposition. The results are published in the Journal of Consumer Psychology.

Is there a relationship between how one responds to food marketing and obesity? While the former is often accused of contributing to the increase in the prevalence of obesity in the population, no relationship between the two at the individual level has yet been established since marketing studies rarely investigate respondents with obesity. If there is such a relationship, does bariatric surgery, one of the most successful current weight loss interventions for people with severe obesity, influence this response to food marketing?

 

To explore these questions, researchers from the Paris Brain Institute, INSEAD, the Nutrition Department of the Pitié-Salpêtrière Hospital, EPHE and University of British Columbia, studied the responses of 3 groups of individuals to the classic food marketing tactics of presenting food as healthier than it really is. The first group consisted of individuals who were obese before, 3 months and 12 months after bariatric surgery. The second was a control group of non-obese individuals. The third was a control group of individuals who were obese but had not taken any steps to lose weight.

 

Their results show that patients with obesity responded more strongly to food marketing tactics prior to bariatric surgery, compared to lean individuals. Interestingly, however, these differences attenuated 12 months after the weight loss surgery.

This first result is very important because it shows that the response to food marketing is not necessarily an individual disposition such as a lack of self-control or a high sensitivity to reward in subjects with obesity per se as previously thought.

Hilke Plassmann INSEAD’s Octapharma Chaired Professor of Decision Neuroscience and researcher at the Paris Brain Institute

A new possible of this work could be the existence of a reinforcement loop between the metabolic state of obesity and responsiveness to food marketing. People with obesity are more responsive to food marketing, which in turn decreases once this metabolic state is changed towards a more metabolic healthy state (i.e., after weight loss going hand in hand with a normalization of various metabolic parameters).

 

Why bariatric surgery is associated with a decreased response to food marketing remains an interesting question for future research. From a neuroscientific point of view, a related study co-authored by Hilke Plassmann and Liane Schmidt at the Paris Brain Institute amongst others, have shown that changes in brain connectivity at rest in reward systems predicts weight loss and correlates with changes post-surgery in the satiety hormone leptin. These findings hint at the idea that bariatric surgery has a much more complex beneficial impact for patients beyond the obvious weight loss.

 

Sources

Obesity and Responsiveness to Food Marketing Before and After Bariatric Surgery. Yann Cornil,  Hilke Plassmann,  Judith Aron‐Wisnewsky,  Christine Poitou‐Bernert,  Karine Clément, Michèle Chabert,  Pierre Chandon. Journal of Consumer Psychology. Feb 2021.
https://pubmed.ncbi.nlm.nih.gov/33615220/
https://doi.org/10.1002/jcpy.1221

Our news on the subject

Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
Une nouvelle approche pour évaluer les patients en état de conscience altérée
A New Approach to Assessing Patients with Disorders of Consciousness
In intensive care units, some patients who appear unconscious occupy a gray zone in their relationship to the world. To better diagnose them and predict their recovery potential, Dragana Manasova, Jacobo Sitt, and their colleagues have developed an...
01.08.2026 Research, science & health
Ne plus penser à rien : vers une signature cérébrale du blanc mental
Not Thinking About Anything: Toward a Brain Signature of Mind Blanking
What if the flow of our thoughts occasionally just stopped? Esteban Munoz-Musat, Lionel Naccache, Thomas Andrillon, and their colleagues at Paris Brain Institute and Monash University in Melbourne show that the sensation of “thinking about nothing”...
12.26.2025 Research, science & health
Deux nouvelles certifications pour les plateformes de l’Institut du Cerveau
Two new certifications for Paris Brain Institute’s core facilities
Paris Brain Institute’s core facilities were recently awarded two new certifications: ISO 9001 certification for ICM.Quant and ISO 20387 certification for its DNA & Cell Bank.
11.14.2025 Institutional
La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
See all our news